European Journal of Internal Medicine
Volume 18, Issue 1 , Pages 6-17 , January 2007

The diagnosis and treatment of male osteoporosis: Defining, assessing, and preventing skeletal fragility in men

  • Steven Boonen

      Affiliations

    • Leuven University Center for Metabolic Bone Diseases, Katholieke Universiteit Leuven, Leuven, Belgium
    • The Leuven University Department of Geriatric Medicine, Katholieke Universiteit Leuven, Leuven, Belgium
    • The Leuven University Laboratory for Experimental Medicine, Katholieke Universiteit Leuven, Leuven, Belgium
    • Corresponding Author InformationCorresponding author. Leuven University Center for Metabolic Bone Diseases and Division of Geriatric Medicine, Universitaire Ziekenhuizen K.U. Leuven, Herestraat 49, B-3000 Leuven, Belgium.
    • ,
  • Jean-Marc Kaufman

      Affiliations

    • Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital, Ghent, Belgium
    • ,
  • Stefan Goemaere

      Affiliations

    • Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital, Ghent, Belgium
    • ,
  • Roger Bouillon

      Affiliations

    • Leuven University Center for Metabolic Bone Diseases, Katholieke Universiteit Leuven, Leuven, Belgium
    • The Leuven University Department of Geriatric Medicine, Katholieke Universiteit Leuven, Leuven, Belgium
    • ,
  • Dirk Vanderschueren

      Affiliations

    • Leuven University Center for Metabolic Bone Diseases, Katholieke Universiteit Leuven, Leuven, Belgium
    • The Leuven University Department of Geriatric Medicine, Katholieke Universiteit Leuven, Leuven, Belgium

Received 6 February 2006 ,Revised 5 September 2006 ,Accepted 19 September 2006.

References 

  1. Orwoll ES. Osteoporosis in men. Endocrinol Metab Clin N Am. 1998;27:349–367
  2. Seeman E. Osteoporosis in men. Osteoporos Int. 1999;9(2 Suppl):S97–S110
  3. Bilezikian JP. Osteoporosis in men. J Clin Endocrinol Metab. 1999;84:3431–3434
  4. Ebeling P. Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management. Drugs Aging. 1998;13:421–434
  5. Siddiqui N, Shetty K, Duthie E. Osteoporosis in older men. Geriatrics. 1999;54:20–28
  6. Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev. 1995;16:87–116
  7. Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–289
  8. De Laet C, Van Hout B, Burger H, Hofman A, Pols H. Bone density and risk of hip fracture in men and women. BMJ. 1997;315:221–225
  9. Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA. Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int. 1994;4:277–282
  10. Schwartz AV, Kelsey JL, Maggi S, Tuttleman M, Ho SC, Jonsson PV, et al International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on Aging. Osteoporos Int. 1999;9:242–253
  11. Elffors I, Allander E, Kanis JA, Gullberg B, Johnell O, Dequeker J, et al. The variable incidence of hip fracture in southern Europe: the MEDOS study. Osteoporos Int. 1994;4:253–263
  12. Sanders KM, Seeman E, Ugoni AM, Pasco JA, Martin TJ, Skoric B, et al. Age- and gender-specific rate of fractures in Australia: a population-based study. Osteoporos Int. 1999;10:240–247
  13. Huuskonen J, Kroger H, Arnala I, Alhava E. Characteristics of male hip fracture patients. Ann Chir Gynaecol. 1999;88:48–53
  14. Poor G, Atkinson EJ, O'Fallon WM, Melton LJ. Predictors of hip fractures in elderly men. J Bone Miner Res. 1995;10:1900–1907
  15. Poor G, Atkinson EJ, Lewallen DG, O'Fallon WM, Melton LJ. Age-related hip fractures in men: clinical spectrum and short-term outcomes. Osteoporos Int. 1995;5:419–426
  16. Schurch MA, Rizzoli R, Mermillod B, Vasey H, Michel JP, Bonjour JP. A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res. 1996;11:1935–1942
  17. Poor G, Atkinson EJ, O'Fallon WM, Melton LJ. Determinants of reduced survival following hip fractures in men. Clin Orthop. 1995;46:260–265
  18. Melton LJ. Epidemiology of spinal osteoporosis. Spine. 1997;22:2S–11S
  19. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res. 1992;7:221–227
  20. Szulc P, Marchand F, Felsenberg D, Delmas PD. Prevalence of vertebral deformities according to the diagnostic method. Rev Rhum Engl Ed. 1998;65:245–256
  21. O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res. 1996;11:1010–1018
  22. Mann T, Oviatt SK, Wilson D, Nelson D, Orwoll ES. Vertebral deformity in men. J Bone Miner Res. 1992;7:1259–1265
  23. Davies KM, Stegman MR, Heaney RP, Recker RR. Prevalence and severity of vertebral fracture: the Saunders County Bone Quality Study. Osteoporos Int. 1996;6:160–165
  24. Lunt M, Felsenberg D, Reeve J, Benevolenskaya L, Cannata J, Dequeker J, et al. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS study. J Bone Miner Res. 1997;12:1883–1894
  25. Matthis C, Weber U, O'Neill TW, Raspe H. Health impact associated with vertebral deformities: results from the European Vertebral Osteoporosis Study (EVOS). Osteoporos Int. 1998;8:364–372
  26. Melton LJ, Amadio PC, Crowson CS, O'Fallon WM. Long-term trends in the incidence of distal forearm fractures. Osteoporos Int. 1998;8:341–348
  27. Haentjens P, Johnell O, Kanis J, Bouillon R, Cooper C, Lamraski G, et al. Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in Caucasian men. J Bone Miner Res. 2004;19:1933–1944
  28. Greenspan SL, Myers ER, Maitland LA, Resnick NM, Hayes WC. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA. 1994;271:128–133
  29. Winner SJ, Morgan CA, Evans JG. Perimenopausal risk of falling and incidence of distal forearm fracture. Br Med J. 1989;298:1486–1488
  30. Greenspan SL, Myers ER, Kiel DP, Parker RA, Hayes WC, Resnick NM. Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. Am J Med. 1998;104:539–545
  31. Mussolino ME, Looker AC, Madans JH, Langlois JA, Orwoll ES. Risk factors for hip fracture in white men: the NHANES I Epidemiologic Follow-up Study. J Bone Miner Res. 1998;13:918–924
  32. Grisso JA, Chiu GY, Maislin G, Steinmann WC, Portale J. Risk factors for hip fractures in men: a preliminary study. J Bone Miner Res. 1991;6:865–868
  33. Kanis J, Johnell O, Gullberg B, Allander E, Elffors L, Ranstam J, et al. Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int. 1999;9:45–54
  34. Nguyen T, Sambrook P, Kelly P, Jones G, Lord S, Freund J, et al. Prediction of osteoporotic fractures by postural instability and bone density. Br Med J. 1993;307:1111–1115
  35. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol. 1996;144:255–263
  36. Grisso JA, Kelsey JL, O'Brien LA, Miles CG, Sidney S, Maislin G, et al. Risk factors for hip fracture in men. Am J Epidemiol. 1997;145:786–793
  37. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368–381
  38. Looker AC, Orwoll ES, Johnston CC, Lindsay RL, Wahner HW, Dunn WL, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761–1768
  39. Aaron JE, Makins NB, Sagreiya K. The microanatomy of trabecular bone loss in normal aging men and women. Clin Orthop. 1987;83:260–271
  40. Mosekilde L. Vertebral structure and strength in vivo and in vitro. Calcif Tissue Int. 1993;53(1 Suppl):S121–S125
  41. Mosekilde L. The effect of modelling and remodelling on human vertebral body architecture. Technol Health Care. 1998;6:287–297
  42. Audran M, Chappard D, Legrand E, Libouban H, Basle MF. Bone microarchitecture and bone fragility in men: DXA and histomorphometry in humans and in the orchidectomized rat model. Calcif Tissue Int. 2001;69:214–217
  43. Chavassieux P, Meunier PJ. Histomorphometric approach of bone loss in men. Calcif Tissue Int. 2001;69:209–213
  44. De Laet CE, Van Hout BA, Burger H, Hofman A, Pols HA. Bone density and risk of hip fracture in men and women: cross-sectional analysis. BMJ. 1997;315:221–225
  45. Melton L, Atkinson E, O'Connor M, O'Fallon W, Riggs B. Bone density and fracture risk in men. J Bone Miner Res. 1998;12:1915–1923
  46. Selby P, Davies M, Adams J. Do men and women fracture bones at similar bone densities?. Osteoporos Int. 2000;11:153–157
  47. Lunt M, O'Neill T, Felsenberg D, Silman A, Reeve J. Age and bone mineral density have similar effects on the risk of incident vertebral deformity in men and women: results from the European prospective osteoporosis study. Osteoporos Int. 2000;11(1 Suppl):S58–S59
  48. De Laet CE, Van Hout BA, Burger H, Weel AE, Hofman A, Pols HA. Hip fracture prediction in elderly men and women: validation in the Rotterdam study. J Bone Miner Res. 1998;13:1587–1593
  49. Kanis JA, Johnell O, Oden A, De Laet C, Mellstrom D. Diagnosis of osteoporosis and fracture threshold in men. Calcif Tissue Int. 2001;69:218–221
  50. Leslie WD, Adler RA, El-Hajj Fuleihan G, Hodsman AB, Kendler DL, McClung M, et al. Application of the WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions. J Clin Densitom. 2006;9:22–30
  51. Boonen S, Vanderschueren D, Geusens P, Bouillon R. Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. Int J Androl. 1997;20:134–143
  52. Boonen S, Vanderschueren D, Cheng XG, Verbeke G, Dequeker J, Geusens P, et al. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption. J Bone Miner Res. 1997;12:2119–2126
  53. Vanderschueren D, Vandenput L, Boonen S, Van Herck E, Swinnen J, Bouillon R. An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement. Endocrinology. 2000;141:1642–1647
  54. Rapado A, Hawkins F, Sobrinho L, Diaz-Curiel M, Galvao-Telles A, Arver S, et al. Bone mineral density and androgen levels in elderly males. Calcif Tissue Int. 1999;65:417–421
  55. Slemenda CW, Longcope C, Zhou L, Hui SL, Peacock M, Johnston CC. Sex steroids and bone mass in older men. Positive associations with serum ooestrogens and negative associations with androgens. J Clin Invest. 1997;100:1755–1759
  56. Khosla S, Melton LJ, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable oestrogen. J Clin Endocrinol Metab. 1998;83:2266–2274
  57. Center JR, Nguyen TV, Sambrook PN, Eisman JA. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Bone Miner Res. 1999;84:3626–3635
  58. Riggs BL, Khosla S, Melton LJ. A unitary model for involutional osteoporosis: oestrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998;13:763–773
  59. Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res. 1997;12:1833–1843
  60. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of oestrogens. J Clin Endocrinol Metab. 1995;80:3689–3698
  61. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331:1056–1061
  62. Vanderschueren D, Boonen S, Bouillon R. Action of androgens versus oestrogens in male skeletal homeostasis. Bone. 1998;23:391–394
  63. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of oestrogen therapy in a man with aromatase deficiency. N Engl J Med. 1998;339:599–603
  64. Bouillon R, Bex M, Vanderschueren D, Boonen S. Exposure to estrogen essential for male pubertal periosteal bone expansion. J Clin Endocrinol Metab. 2004;89:6025–6029
  65. Barrett-Connor E, Mueller J, Van Mühlen D, Laughlin G, Schneider D, Sartoris D. Low levels of estradiol are associated with vertebral fractures in older men but not women: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2000;85:219–223
  66. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000;106:1553–1560
  67. Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG. Severe osteoporosis in men. Ann Intern Med. 1995;123:452–460
  68. Scane AC, Francis RM, Sutcliffe AM, Francis MJ, Rawlings DJ, Chapple CL. Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporos Int. 1999;9:91–97
  69. Legrand E, Chappard D, Pascaretti C, Duquenne M, Krebs S, Rohmer V, et al. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. J Bone Miner Res. 2000;15:13–19
  70. Compston J. Secondary causes of osteoporosis in men. Calcif Tissue Int. 2001;193–195
  71. Seeman E, Melton LJ, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med. 1983;75:977–983
  72. Reid IR. Glucocorticoid osteoporosis: mechanisms and management. Eur J Endocrinol. 1997;137:209–217
  73. Wei JT, Gross M, Jaffe CA, Gravlin K, Lahaie M, Faerber GJ, et al. Androgen deprivation therapy for prostate cancer results in significant loss of bone density. Urology. 1999;54:607–611
  74. Daniell HW. Osteoporosis after orchiectomy for prostate cancer. J Urol. 1997;157:439–444
  75. Diamond T, Campbell J, Bryant C, Lynch W. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer. 1998;83:1561–1566
  76. Eriksson S, Eriksson A, Stege R, Carlstrom K. Bone mineral density in patients with prostatic cancer treated with orchidectomy and with oestrogens. Calcif Tissue Int. 1995;57:97–99
  77. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, et al. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1989;69:776–783
  78. Finkelstein JS, Klibanski A, Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab. 1996;81:1152–1155
  79. Bertelloni S, Baroncelli GI, Ferdeghini M, Perri G, Saggese G. Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty. J Clin Endocrinol Metab. 1998;83:4280–4283
  80. Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?. J Am Geriatr Soc. 1991;39:766–771
  81. Hoidrup S, Gronbaek M, Gottschau A, Lauritzen J, Schroll M. Alcohol intake, beverage preference, and risk of hip fracture in men and women. Am J Epidemiol. 1999;149:993–1001
  82. Burger H, de Laet CE, van Daele PL, Weel AE, Witteman JC, Hofman A, et al. Risk factors for increased bone loss in an elderly population: the Rotterdam study. Am J Epidemiol. 1998;147:871–879
  83. Burger H, De Laet CE, Weel AE, Hofman A, Pols HA. Added value of bone mineral density in hip fracture risk scores. Bone. 1999;25:369–374
  84. Perry HM, Fallon MD, Bergfeld M, Teitelbaum SL, Avioli LV. Osteoporosis in young men: a syndrome of hypercalciuria and accelerated bone turnover. Arch Intern Med. 1982;142:1295–1298
  85. Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int. 1992;2:128–134
  86. Khosla S, Lufkin EG, Hodgson SF, Fitzpatrick LA, Melton LJ. Epidemiology and clinical features of osteoporosis in young individuals. Bone. 1994;15:551–555
  87. Bilezikian JP, Kurland ES, Rosen CJ. Male skeletal health and osteoporosis. Trends Endocrinol Metab. 1999;10:244–250
  88. Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, et al. Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab. 1997;82:2799–2805
  89. Block JE, Stubbs H. Hip fracture-associated mortality reconsidered. Calcif Tissue Int. 1997;61:84
  90. Johansson AG, Eriksen EF, Lindh E, Langdahl B, Blum WF, Lindahl A, et al. Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J Clin Endocrinol Metab. 1997;82:2795–2798
  91. Ljunghall S, Johansson AG, Burman P, Kampe O, Lindh E, Karlsson FA. Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis. J Intern Med. 1992;232:59–64
  92. Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res. 1995;10:1218–1224
  93. Kurland ES, Chan FK, Rosen CJ, Bilezikian JP. Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab. 1998;83:2576–2579
  94. Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab. 1998;83:2286–2290
  95. Gillberg P, Johansson AG, Ljunghall S. Decreased oestradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis. Calcif Tissue Int. 1999;64:209–213
  96. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666–3672
  97. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670–676
  98. Orwoll ES, Oviatt SK, Mclung MR, Deftos LJ, Sexton G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med. 1990;112:29–34
  99. Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ. 2005;330:1003–1008
  100. The RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005;365:1621–1628
  101. Jackson RD, Lacroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354:669–683
  102. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis: a clinical update. J Intern Med. 2006;259:539–552
  103. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996;81:4358–4365
  104. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab. 1999;84:1966–1972
  105. Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab. 2004;89:503–510
  106. Neer RM, Arnaud CD, Zanchetta J, Prince R, Gaich GA, Reginster JY, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434–1441
  107. Kaufman JM, Orwoll E, Goemaere S, San Martin J, Hossain A, Dalsky G, et al. Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int. 2005;16:510–516
  108. Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R, et al. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther. 1999;21:1025–1044
  109. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 1997;337:382–387
  110. Orwoll ES, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343:604–610
  111. Reid DM, Adami S, Devogelaer J-P, Chines AA. Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. Calcif Tissue Int. 2001;69:242–247

PII: S0953-6205(06)00249-4

doi: 10.1016/j.ejim.2006.09.005

European Journal of Internal Medicine
Volume 18, Issue 1 , Pages 6-17 , January 2007

Article Tools